A group of international experts is proposing a first-of-its-kind framework to prevent multiple sclerosis (MS) from ...

Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its ...

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of ...

The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...

The immune system's reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple ...

The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...

New research suggests that balance and coordination problems in multiple sclerosis may begin when key brain cells slowly run ...

Other prenatal exposures -- preterm birth (before 37 weeks gestation), placental abruption, and maternal hypertensive ...

One of the leading triggers for multiple sclerosis (MS) is an infection with the Epstein-Barr virus. However, certain gene variants also play an important role.

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...